Guest guest Posted November 1, 2002 Report Share Posted November 1, 2002 REFERENCES AND NOTES 1. Brian Howe, " The cost of health care is rocketing " , Sunday Telegraph, 27 Oct. 1992. 2. Ivan Illich, Limits to Medicine - Medical Nemesis: The Expropriation of Health, Pelican Books, 1979, pp. 57-8. 2a. Robert W. Hetherington, Carl E. Hopkins, and Milton I. Roemer, Health Insurance Plans: Promise and Performance, Wiley, New York, 1975. Cited in ref. 2, p. 57. 2b. Martin S. Feldstein, The Rising Cost of Hospital Care, Information Resources, Washington, D.C., 1971. Cited in ref. 2, p. 57. 2c. CREDOC (Centre de recherches et de documentation sur la consommation), Evolution de la structure des soins medicaus, 1957- 1972, Paris, 1973. Cited in ref. 2, p. 57. 2d. " Krankheitskosten: 'Die bombe tickt'; Das westdeutsche Gesundheitswesen " , 1. " Der Kampf um die Kassen-Milliarden " ; 2. " Die Phalanx der niedergelassenen Arzte " , Der Spiegel, no. 19, 1975, pp. 54-66; no. 20, 1975, pp. 126-42. Cited in ref. 2, p. 57. 2e. R. Maxwell, Health Care: The Proving Dilemma; Needs vs. Resouces in Western Europe, the U.S., and the U.S.S.R., McKinsey & Co., New York, 1974. Ian Douglas-Wilson and Gordon McLachlan, eds, Health Service Projects: An International Survey, Little, Brown, Boston, 1973. Cited in ref. 2, p. 57. 2f. Louise Russell et al., Federal Health Spending, 1969-74, Center for Health Policy Studies, National Planning Association, Washington, D.C., 1974. Cited in ref. 2, p. 58. 3. " Drug doctors under fire " , Bulletin, 24 Mar. 1992, pp. 20-1. 4. Illich, op. cit., pp. 77-8. 4a. John M. Firestone, Trends in Prescription Drug Prices, Enterprise Institute for Public Policy Research, Washington, D.C., 1970. Cited in ref. 4, p. 77. 4b. Edward M. Brecher and Consumer Reports Editors, Licit and Illicit Drugs: The Consumers Union Report on Narcotics, Stimulants, Depressants, Inhalants, Hallucinogens and Marijuana - Including Caffeine, Nicotine and Alcohol, Little, Brown, Boston, 1973. Cited in ref. 4, p. 78. 4c. D.M. Dunlop, " The use and abuse of psychotropic drugs " , in Proceedings of the Royal Society of Medicine (1970) 63: 1279. G. L. Klerman, " Social values and the consumption of psychotropic medicine " , in Proceedings of the First World Congress on Environmental Medicine and Biology, North-Holland, Haarlem, 1974. Cited in ref. 4, p. 78. 4d. James L. Goddard, " The medical business " , Scientific American, no. 229, Sept. 1973, pp. 161-6. Cited in ref. 4, p. 78. 4e. Drug Use in America: Problem in Perspective, Second Report of the National Commission on Marihuana and Drug Abuse, 1972, 1973, 1974, 4 vols, Government Printing Office, Washington, D.C., stock no. 5266- 0003. National Commission for the Study of Nursing and Nursing Education, An Abstract for Action, McGraw-Hill, New York, 1970. Cited in ref. 4, p. 78. 5. Illich, op. cit., p. 36. 6. Robert S. Mendelsohn, Confessions of a Medical Heretic, Warner Books, New York, 1980, p. 56. 7. National Health Stategy, Issues in Pharmaceutical Drug Use in Australia, Issues Paper no. 4 (Prof. R. Harvey, Chairman), National Health, Housing and Community Services, Canberra, June 1992, p. 50. 8. " The alternatives to pill-popping " , Sydney Morning Herald, 2 July 1988. 9. D. Wade, " The background pattern of drug usage in Australia " , Clinical Pharmacology and Therapeutics, vol. 19, May 1976, pp. 651-6. 10. Calculated by comparing statistics provided in refs 7 & 8. 11. Australian Consumers' Association, " Pills for Pain " , Choice, ACA, Marrickville, NSW, June 1991, p. 11. 12. In 1973, $166 million was spent on OTC drugs (see ref. 11) and $240 million was spent on prescription drugs (Pharmacy Guild of Australia, Guild Digest, 1991, tables 27 & 31). From this it was calculated that in 1973 the cost of OTC was 69% of the cost of prescription drugs. If the rate of increase of OTC drugs is proportional to the rate of increase of prescription drugs, then it could be estimated that OTC drugs in 1991 would amount to 69% of $2 billion (cost of prescription drugs in 1991. See ref. 3), which equals to $1.4 billion. 13. See ref. 3. 14. Jim Mason & Peter Singer, Animal Factories, Crown Publishers, New York, 1980, p. 56. 15. John Robins, Diet for a New America, Stillpoint Publishing, Walpole, 1987, p. 109. 16. Bureau of Veterinary Medicine, Department of Health, Education and Welfare, FDA 76-6012, " Drug use guide: swine " , B.V.M., Industry Relations Branch, Rockville, Md., May 1976, p. 1. 17. Drugs in Livestock Feed, vol. I, Technical Report, Office of Technology Assessment, Washington, D.C., June 1979, p. 3. 18. Food Safety and Quality Service, U.S. Department of Agriculture, " Industry-government 'self-help' sulfa campaign underway " , Northeast Regional Information Office Newsletter, New York, 15 June 1978, p. 1. 19. Drugs in Livestock Feed, op. cit., vol. I, p. 3. 20. Illich, op. cit., p. 79. 21. Hans Ruesch, Naked Empress or The Great Medical Fraud, CIVIS (Latin acronym for International Center of Scientific Information on Vivisection) Publications, POB 152, Via Motta 51, CH-6900 Massagno/Lugano, Switzerland, 1992, p. 12. 22. R.D. Mann, Modern Drug Use, an Enquiry on Historical Principles, MTP Press, 1984. 23. FDA Drug Review: Postapproval Risks 1976-1985, U.S. General Accounting Office, April 1990. 24. Adverse Drug Reaction Advisory Committee, The New Epidemic: A Collection of Case-Studies by ADRAC, AGPS, Canberra, 1987, p. 3. 25. I. Lamour, R.G. Dolphin, H. Baxter et al., " A prospective study of hospital admissions due to drug reactions " , Australian Journal of Hospital Pharmacy, 1991, vol. 21(2), pp. 90-95. 26. " A crisis of confidence " , Australian Penthouse, April 1983, p. 39. 27. R.D. Mann, op. cit. 28. Richard Taylor, Medicine Out of Control - The Anatomy of a Malignant Technology, Sun Books, Melbourne, 1979, p. 46. 29. Leighton Cluff in Controversies in Therapeutics, ed. Louis Lasagna, Saunders, 1980, p. 44. 30. U.S. Senate, Select Committee on Small Business, Subcommittee on Monopoly, Competitive Problems in the Drug Industry, 90th Congress, 1st & 2nd Sessions, 1967-8, pt. 2, p. 565. 31. Leighton Cluff, op. cit. 32. Arabella Melville & Colin Johnson, Cured to Death - The Effects of Prescription Drugs, Angus & Robertson Publishers, London, 1982, p. 123. 33. Health Care Reform Group, Compulsory Immunisation - A Statement of Concern, HCRG, Glebe, NSW, 1991, p. 13. 34. New Scientist, no. 218, 17 July 1980. 35. W.H. Inman in Monitoring for Drug Safety, ed. W.H. Inman, MTP Press, 1980. 36. Taylor, op. cit., pp. 46-7. 37. H. Beaty & R. Petersdorf, " Iatrogenic factors in infectious disease " , Annals of Internal Medicine, 1966, vol. 65, p. 641. 38. Taylor, op. cit., pp. 47-8. 39. Robert S. Mendelsohn, Confessions of a Medical Heretic, Warner Books, New York, 1980. 40. Robert S. Mendelsohn, Mal(e) Practice: How Doctors Manipulate Women, Contemporary Books, Chicago, 1982. 41. Robert S. Mendelsohn, How to Raise a Healthy Child...In Spite of Your Doctor, Ballantine Books, New York, 1987. 42. Illich, op. cit., p. 35. 43. Ruesch, op. cit., p. 13. 44. ibid. 45. ibid. 46. U.S. Department of Health & Human Services, Ten Leading Causes of Death in the U.S., 1977, July 1980. 47. T. McKeown, The Role of Medicine, Blackwell Scientific Publications, 1979. 48. T. McKeown and C.R. Lowe, An Introduction to Social Medicine, Blackwell Scientific Publications, 1976. 49. J.B. McKinlay & S. McKinlay, Health & Society, Millibank Memorial Fund, 1977, pp. 405-28. 50. Wisconsin Action Coalition and Citizen Fund of Washington, D.C., Milwaukee Sentinel, 30 Apr. 1990. 51. Alan S. Levin, " Corruption in American medicine " , in Dissent in Medicine - Nine Doctors Speak Out, The New Medical Foundation, 36th Floor, 115 South LaSalle Street, Chicago, Illinois 60603, publ. by Contemporary Books, Chicago, pp. 78-80. 52. See ref. 3. 53. Levin, op. cit., pp. 80-4. 54. Illich, op. cit., p. 11. 55. Hans Ruesch, Naked Empress or The Great Medical Fraud, CIVIS Publications, Massagno/Lugano, Switzerland, 1992. 56. Morris A. Bealle, The Drug Story, Biworld Publishers, Orem, Utah, 1949 (original edition titled as The Super Drug Story, publ. by Columbia Publishing Company, Washington, D.C.; also retitled as The New Drug Story) , Cited in ref. 55, pp. 98-9. 57. ibid. 58. Joseph Borkin, The Crime and Punishment of I.G. Farben, Free Press, New York, 1978, p. 127. 59. John Braithwaite, Corporate Crime in the Pharmaceutical Industry, Routledge & Kegan Paul, London, 1984, p. 4. 60. Borkin, op. cit. 61. ibid. 62. Bealle, op. cit., reproduced in ref. 55, p. 100. 63. Ruesch, op. cit., p. 116. 64. Bealle, op. cit. repr. in ref. 55, pp. 100-1. 65. Ruesch, op. cit., pp. 101-2. 66. ibid., pp. 103-4. 67. ibid., p. 105. 68. Bealle, op. cit., repr. in ref. 67. 69. Ruesch, op. cit., pp. 105-6. 70. Bina Robinson (ed.), " FDA: The American gestapo protector or prosecuter? " , Civil Abolitionist, P.O. Box 26, Swain, New York 14885, vol., IV, no., 3, Summer 1992, ps 1 & 7. 71. Duncan Roads (ed.), " Alternative medicine beware " , Nexus New Times, vol. 2, no. 8, June-July 1992, p. 9. 72. Duncan Roads (ed.), " Natural medicine in the USA - a warning to Australia " , Nexus New Times, vol. 2, no. 9, Aug.-Sept. 1992, p. 9. 73. Freedom of Choice in Health Care, circular, FCHC - P.O. Box 2651, Alice Springs, NT. 0870, 1992. 74. See ref. 72. 75. Ruesch, op. cit., pp. 108-9. 76. ibid., p. 106. 77. J.W. Hodge quoted in ref. 75. 78. " Unorthodox medicos to lose rebates " , Australian, 21 July 1992, p. 3. 79. Woodrow Wilson in The New Freedom, Doubleday & Co., New York, 1913, pp. 57-8. Repr. in ref. 55, p. 117. 80. Ruesch, op. cit., p. 118. 81. Morris H. Rubin (ed.), The Progressive, Jan. 1977. Repr. in ref. 55, p. 119. 82. Jimmy Carter in AMA News, 8 June 1979. 83. Cary Allen, None Dare Call It Conspiracy, Concord Press - P.O. Box 2686, Seal Beach, California 90740, 1971 Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.